Work

Final Results of a Phase I/II Trial of the Combination of Concurrent Lenalidomide, Thalidomide and Dexamethasone in Patients with Relapsed and/or Refractory Myeloma

Year: 2012

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v120.21.75.75

Authors: Jatin J. Shah, Robert Z. Orlowski, Sheeba K. Thomas, Raymond Alexanian, Michael Wang, Muzaffar H. Qazilbash, Uday R. Popat, Simrit Parmar, Nina Shah, Qaiser Bashir, Richard E. Champlin, Donna M. Weber

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2564760037

FWCI: 0.423

Cites:

Cited by: 4

Related to: 10